Business UpdateJun 2, 2026, 07:46 AM
Quantum BioPharma Engages Stocks.news for Investor Relations
AI Summary
Quantum BioPharma Ltd. announced it has entered into an investor relations and consulting services agreement with Stocks.news through IR Agency LLC. The agreement, effective June 8, 2026, is for a period of six months and includes services such as company profiling, media distribution, digital community building, and lead generation campaigns. The total fee for these services is US$250,000.
Key Highlights
- Quantum BioPharma engaged Stocks.news through IR Agency LLC for investor relations and consulting services.
- The agreement commenced on June 8, 2026, for a period of 6 months.
- The services include creating company profiles, media distribution, digital community building, marketing news, and lead generation campaigns.
- The total fee for the services is US$250,000.
- The Agency is arm's-length to the Company and holds no equity interest in Quantum BioPharma securities.
Price Impact
More from QNTM